$24.40
-0.17-0.71%
At close: -
iShares Health Innovation Active ETF (ARCA: BMED)
Ticker | Name | Share % | |
---|---|---|---|
XTSLA | Blackrock Cash Funds: Treasury, Sl Agency Shares | 6.24% | |
BSX | Boston Scientific Corp. | 3.62% | |
COR | Cencora Inc | 3.48% | |
ISRG | Intuitive Surgical Inc. | 2.82% | |
AS | Argenx Se | 2.68% | |
ALNY | Alnylam Pharmaceuticals Inc Common Stock Usd 0.01 | 2.59% | |
MTD | Mettler-Toledo International Inc. | 2.52% | |
WST | West Pharmaceutical Services Inc | 2.48% | |
AMGN | Amgen Inc 2.2 5/19 | 2.43% | |
DHR | Danaher Corp. | 2.04% |
The BMED ETF is currently trading at $0.00, which represents a -0.71% change. Over the past 52 weeks, the ETF has traded as high as $27.02 and as low as $23.99.
The expense ratio of BMED is NA%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for BMED is 4.10M. This represents the total market value of the assets managed by the ETF.
BMED follows a All Cap Blend investment style.
The top holdings of BMED include: XTSLA (6.24%), BSX (3.62%), COR (3.48%), ISRG (2.82%), AS (2.68%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BMED is currently not available.